London, United Kingdom

Gautam Mehta

This inventor holds 1 USPTO granted patent and 2 published patent applications. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gautam Mehta. Retrieved from https://idiyas.com/inventor/gautam-mehta

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Liver Failure Treatment by Gautam Mehta

Introduction

Gautam Mehta is an innovative inventor based in London, GB. He has made significant contributions to the field of medical research, particularly in the treatment of liver failure. His work focuses on understanding and targeting pyroptosis, a form of programmed cell death that plays a crucial role in various diseases.

Latest Patents

Gautam Mehta holds a patent for his invention titled "Treatment of pyroptosis." This groundbreaking patent stems from the discovery that pyroptosis serves as a novel biomarker and therapeutic target for conditions such as acute liver failure (ALF) and acute-on-chronic liver failure (ACLF). The invention highlights the detection and quantification of Gasdermin D (GSDMD), caspase 4, caspase 5, and Interleukin 1 alpha (IL-1α) in serum or plasma. These biomarkers can be utilized to assess outcomes in liver failure and other diseases associated with aberrant pyroptosis. By antagonizing these components, the invention aims to mitigate the adverse effects and symptoms associated with liver failure.

Career Highlights

Throughout his career, Gautam Mehta has focused on advancing medical science through innovative research. His findings have the potential to revolutionize the treatment of liver-related diseases, providing new avenues for therapy and prevention. The implications of his work extend beyond liver failure, as it also addresses aberrant pyroptosis in other organs, including the kidney and brain.

Collaborations

Gautam Mehta has collaborated with notable researchers in the field, including Rajiv Jalan and Ugo Soffientini. These partnerships have enhanced the depth and impact of his research, contributing to the development of effective treatments for liver failure.

Conclusion

Gautam Mehta's innovative work in the treatment of pyroptosis represents a significant advancement in medical research. His patent offers promising solutions for managing liver failure and highlights the importance of targeted therapies in modern medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…